Browsing Tag

Special Reports

58 posts

DCAT Week ’18: CordenPharma Outlines Integration of Former Pfizer API Facility
By

By
  Jason BertolaDirector, Global Highly Potent & Oncology PlatformCordenPharma Jason Bertola, Director, Global Highly Potent & Oncology Platform, CordenPharma International, outlined the company’s integration of its acquisition of a former…

DCAT Week ’18: Catalent Updates Integration of $950-Million Acquisition of Cook Pharmica
By

By
  Aileen RuffVice President, Business Unit Strategy & Marketing, Biologics & Specialty Drug DeliveryCatalent Pharma Solutions Aileen Ruff, Vice President, Business Unit Strategy and Marketing, Biologics and Specialty Drug Delivery,…

DCAT Week ’18: AB BioTechnologies Announces $12-Million Expansion
By

By
  Jeff Schwegman, PhDCEO and FounderAB BioTechnologies Jeff Schwegman, PhD, CEO, and founder of AB BioTechnologies (AB), a Bloomington, Indiana-based life-sciences contract service provider, outlined the company’s recent investment in…

DCAT Week ’18: CDMOs, CMOs, and Suppliers: Expansion Roundups
By

By
What have been the key developments from contract development and manufacturing organizations (CDMOs), contract manufacturing organizations (CMOs), and other suppliers and companies supporting pharmaceutical /biopharmaceutical development and manufacturing thus far…

The Pharma Industry: Now and Beyond
By

By
How did the pharmaceutical industry perform in 2017, and what is the outlook for 2018 and beyond? Key for the industry is the performance of the US market, the largest…

Taking it to the Next Level: Innovation in Sourcing and Procurement
By

By
What does it take to drive innovation to improve business outcomes? Partnership strategies are key, according to a recent PwC study, a subject that will be explored at DCAT Week…

Pharma Manufacturing: What Is Next?
By

By
An effective supply strategy is crucial for pharmaceutical companies, so what are the challenges that companies face? Managing risk, addressing shifts in product mix, and increasingly complex supply chains are…

The R&D Imperative: An Executive View
By

By
Biopharmaceutical companies invest approximately $75 billion annually in R&D in the US, more than any other industry in the US. There are more than 7,000 drugs in development, with more…

APIs: Evaluating Supply and Demand
By

By
The market for active pharmaceutical ingredients (APIs) is approximately $140 billion and is projected to reach nearly $190 billion by 2020. So what does the market show? The API market…

Best Practices in Sourcing and Procurement at DCAT Sharp Sourcing
By

By
Sourcing, procurement, and supply management professionals are faced with an ongoing challenge: reduce costs while adding greater value for their companies. So what are some best practices to achieve this…